| Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... The Lancet 395 (10241), 1907-1918, 2020 | 1817 | 2020 |
| Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline DL Hershman, C Lacchetti, RH Dworkin, EM Lavoie Smith, J Bleeker, ... J Clin Oncol 32 (18), 1941-1967, 2014 | 1380 | 2014 |
| Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update CL Loprinzi, C Lacchetti, J Bleeker, G Cavaletti, C Chauhan, DL Hertz, ... Journal of Clinical Oncology 38 (28), 3325-3348, 2020 | 569 | 2020 |
| Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium P Grivas, AR Khaki, TM Wise-Draper, B French, C Hennessy, CY Hsu, ... Annals of oncology 32 (6), 787-800, 2021 | 281 | 2021 |
| Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update J Bohlius, K Bohlke, R Castelli, B Djulbegovic, MB Lustberg, M Martino, ... Blood advances 3 (8), 1197-1210, 2019 | 199 | 2019 |
| Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19 MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ... JAMA oncology 7 (8), 1167-1175, 2021 | 169 | 2021 |
| Bone health in adult cancer survivorship MB Lustberg, RE Reinbolt, CL Shapiro Journal of Clinical Oncology 30 (30), 3665-3674, 2012 | 137 | 2012 |
| Gene expression patterns through oral squamous cell carcinoma development: PD-L1 expression in primary tumor and circulating tumor cells JP Oliveira-Costa, AF de Carvalho, GG da Silveira, P Amaya, Y Wu, ... Oncotarget 6 (25), 20902, 2015 | 135 | 2015 |
| Addressing the needs of cancer survivors during the COVID-19 pandemic L Nekhlyudov, S Duijts, SV Hudson, JM Jones, J Keogh, B Love, ... Journal of Cancer Survivorship 14, 601-606, 2020 | 129 | 2020 |
| Management of neutropenia in cancer patients MB Lustberg Clinical advances in hematology & oncology: H&O 10 (12), 825, 2012 | 127 | 2012 |
| Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients MB Lustberg, P Balasubramanian, B Miller, A Garcia-Villa, C Deighan, ... Breast Cancer Research 16, 1-15, 2014 | 123 | 2014 |
| Multiparameter analysis, including EMT markers, on negatively enriched blood samples from patients with squamous cell carcinoma of the head and neck P Balasubramanian, JC Lang, KR Jatana, B Miller, E Ozer, M Old, ... Public Library of Science 7 (7), e42048, 2012 | 123 | 2012 |
| Platinum‐induced peripheral neurotoxicity: from pathogenesis to treatment NP Staff, G Cavaletti, B Islam, M Lustberg, D Psimaras, S Tamburin Journal of the Peripheral Nervous System 24, S26-S39, 2019 | 119 | 2019 |
| Triple-negative breast cancer: promising prognostic biomarkers currently in development J Sukumar, K Gast, D Quiroga, M Lustberg, N Williams Expert review of anticancer therapy 21 (2), 135-148, 2021 | 116 | 2021 |
| Gait, balance, and patient-reported outcomes during taxane-based chemotherapy in early-stage breast cancer patients SM Monfort, X Pan, R Patrick, B Ramaswamy, R Wesolowski, ... Breast cancer research and treatment 164, 69-77, 2017 | 110 | 2017 |
| Breast cancer and social environment: getting by with a little help from our friends A Hinzey, MM Gaudier-Diaz, MB Lustberg, AC DeVries Breast Cancer Research 18, 1-9, 2016 | 97 | 2016 |
| Emerging technologies for CTC detection based on depletion of normal cells M Lustberg, KR Jatana, M Zborowski, JJ Chalmers Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer, 97-110, 2012 | 92 | 2012 |
| Incidence, risk factors, and mortality of atrial fibrillation in breast cancer: a SEER-Medicare analysis A Guha, MG Fradley, SF Dent, NL Weintraub, MB Lustberg, A Alonso, ... European heart journal 43 (4), 300-312, 2022 | 91 | 2022 |
| Atrophic vaginitis in breast cancer survivors: a difficult survivorship issue J Lester, G Pahouja, B Andersen, M Lustberg Journal of personalized medicine 5 (2), 50-66, 2015 | 86 | 2015 |
| TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer M Elbaz, D Ahirwar, Z Xiaoli, X Zhou, M Lustberg, MW Nasser, K Shilo, ... Oncotarget 9 (71), 33459, 2018 | 85 | 2018 |
Sagar SardesaiThe Ohio State UniversityVerified email at osumc.edu
